SlidesetRSVCOVID-19Oral Antivirals for COVID-19: How to Best Make Use of Their Therapeutic Effects - Giovanni Di Perri, MD, PhDView Slideset
SlidesetRSVCOVID-19Oral Antivirals for COVID-19: Drug-Drug Interactions as a Manageable Risk - David Burger, PharmD, PhDView Slideset
SlidesetRSVCOVID-19Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience - Part 1 - Catia Marzolini, PharmD, PhDView Slideset
SlidesetRSVCOVID-19Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience – Part 2 - Fiona Marra, MPharm, MScView Slideset
